Compare ACLX & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACLX | GGAL |
|---|---|---|
| Founded | 2015 | 1905 |
| Country | United States | Argentina |
| Employees | N/A | 10079 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.6B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | GGAL |
|---|---|---|
| Price | $115.08 | $43.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | ★ $118.17 | $69.00 |
| AVG Volume (30 Days) | ★ 5.0M | 1.1M |
| Earning Date | 05-06-2026 | 03-07-2023 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,286,000.00 | N/A |
| Revenue This Year | $342.39 | $62.29 |
| Revenue Next Year | $170.71 | $22.88 |
| P/E Ratio | ★ N/A | $13.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.36 | $25.89 |
| 52 Week High | $115.14 | $63.75 |
| Indicator | ACLX | GGAL |
|---|---|---|
| Relative Strength Index (RSI) | 79.86 | 50.98 |
| Support Level | $63.46 | $39.97 |
| Resistance Level | N/A | $45.01 |
| Average True Range (ATR) | 0.11 | 2.03 |
| MACD | -0.62 | 0.28 |
| Stochastic Oscillator | 84.28 | 73.24 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. The company generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.